tiprankstipranks
Trending News
More News >
Ars Pharmaceuticals, Inc. (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Balance Sheet

Compare
564 Followers

ARS Pharmaceuticals Balance Sheet

ARS Pharmaceuticals's total assets for Q4 2025 were $327.65M, a decrease of -12.11% from the previous quarter. SPRY total liabilities were $213.39M for the fiscal quarter, a -5.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Assets
$ 327.65M$ 351.15M$ 233.19M$ 281.44M$ 61.45M
Total Liabilities
$ 213.39M$ 94.36M$ 2.43M$ 8.55M$ 92.72M
Total Equity Gross Minority
$ 114.26M$ 256.80M$ 230.76M$ 272.89M$ -31.27M
Other Metrics
Currency in USD

ARS Pharmaceuticals Debt to Assets